Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/06/19 → 30/11/21 |
Funding
- MRC: £338,804.00
MICA: A phase II trial examining Bermekimab (anti-IL1 alpha) effects on muscle, physical function and appetite, in lung, pancreatic or ovarian cancer
- Symeonides, Stefan (Principal Investigator)
- Fallon, Marie (Co-investigator)
- Hall, Peter (Co-investigator)
- Laird, Barry (Co-investigator)
- Norrie, John (Co-investigator)